Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-045954)

Filing Details

Accession Number:: 0001209191-13-045954
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-09-27 16:49:03
Reporting Period:: 2013-09-25

Filing Date:: 2013-09-27
Accepted Time:: 2013-09-27 16:49:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1385228	Bind Therapeutics Inc	BIND	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1548606	Rusnano	10A 60-Letiya Oktyabrya Prospect Moscow 1Z 117036		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-09-25	1,053,291	$0.00	1,371,357	No	4	C	Direct
Common Stock	Acquisiton	2013-09-25	120,000	$15.00	1,491,357	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series D Preferred Stock	Disposition	2013-09-25	2,759,624	$0.00	1,053,291	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

The convertible preferred stock is convertible at any time, at the holder's election, and has no expiration date. Immediately prior to closing of the issuer's initial public offering, the preferred stock held by the reporting person automatically converted into common stock on a 2.62 to 1 basis.